Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma-Reference-Cited by-同舟云学术

Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma

Published:2021-01 Issue: Volume:142 Page:115607
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Yokomoto-Umakoshi Maki,Umakoshi Hironobu,Sakamoto Ryuichi,Fukumoto Tazuru,Ogata Masatoshi,Nakano Yui,Iwahashi Norifusa,Kaneko Hiroki,Mizoguchi Noriko,Hattori Akiko,Miyazawa Takashi,Matsuda Yayoi,Kawate Hisaya,Ogawa Yoshihiro

Funder

JSPS

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference32 articles.

1. Phaeochromocytoma;Lenders;Lancet.,2015

2. Pheochromocytoma and paraganglioma;Neumann;N. Engl. J. Med.,2019

3. Pheochromocytoma and paraganglioma: an emerging cause of secondary osteoporosis;Yokomoto-Umakoshi;Bone.,2020

4. Bone quality- the material and structural basis of bone strength and fragility;Seeman;N. Engl. J. Med.,2006

5. Trabecular bone score: a noninvasive analytical method based upon the DXA image;Silva;J. Bone Miner. Res.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case–control study from India;Osteoporosis International;2024-07-22

2. Impact of Pheochromocytoma or Paraganglioma on Bone Metabolism: A Systemic Review and Meta-analysis;Journal of Clinical Densitometry;2024-07

3. Deteriorated bone microarchitecture caused by sympathetic overstimulation in pheochromocytoma and paraganglioma;Journal of Endocrinological Investigation;2023-10-24

4. Adrenal steroid metabolites and bone status in patients with adrenal incidentalomas and hypercortisolism;eBioMedicine;2023-09

5. Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging;Osteoporosis International;2023-07-01